Expression of growth hormone-releasing hormone receptor splicing variants in human primary adrenocortical tumours. (Q40430581)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15853821%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

title

Expression of growth hormone-releasing hormone receptor splicing variants in human primary adrenocortical tumours (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15853821%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15853821%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

author name string

Simona Freddi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15853821%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Giorgio Arnaldi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15853821%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Francesca Fazioli

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15853821%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Marina Scarpelli

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15853821%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Gloria Appolloni

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15853821%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Tatiana Mancini

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15853821%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Blerina Kola

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15853821%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Xavier Bertagna

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15853821%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Franco Mantero

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15853821%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Robert Collu

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15853821%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

publication date

1 May 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15853821%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

published in

Clinical Endocrinology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15853821%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

volume

62

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15853821%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15853821%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

page(s)

533-538

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15853821%20AND%20SRC:MED&resulttype=core&format=json

The molecular pathogenesis of hereditary and sporadic adrenocortical and adrenomedullary tumors

11 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02253.X

Synthesis and in vitro evaluation of new potent antagonists of growth hormone-releasing hormone (GH-RH).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02253.X

Synthesis and biological evaluation of antagonists of growth hormone-releasing hormone with high and protracted in vivo activities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02253.X

Increased activity of antagonists of growth hormone-releasing hormone substituted at positions 8, 9, and 10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02253.X

Growth hormone-releasing hormone antagonist MZ-5-156 inhibits growth of DU-145 human androgen-independent prostate carcinoma in nude mice and suppresses the levels and mRNA expression of insulin-like growth factor II in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02253.X

Growth hormone-releasing hormone (GHRH) antagonists inhibit the proliferation of androgen-dependent and -independent prostate cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02253.X

Antagonists of growth hormone-releasing hormone (GH-RH) enhance tumour growth inhibition induced by androgen deprivation in human MDA-Pca-2b prostate cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02253.X

Antagonists of growth hormone-releasing hormone and somatostatin analog RC-160 inhibit the growth of the OV-1063 human epithelial ovarian cancer cell line xenografted into nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02253.X

Human renal cell carcinoma expresses distinct binding sites for growth hormone-releasing hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02253.X

Growth hormone-releasing hormone: an autocrine growth factor for small cell lung carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02253.X

Inhibition of mutant p53 expression and growth of DMS-153 small cell lung carcinoma by antagonists of growth hormone-releasing hormone and bombesin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02253.X

Antagonists of growth hormone-releasing hormone (GH-RH) inhibit in vivo proliferation of experimental pancreatic cancers and decrease IGF-II levels in tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02253.X

Antagonists of growth hormone-releasing hormone (GH-RH) inhibit IGF-II production and growth of HT-29 human colon cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02253.X

Antagonists of growth hormone-releasing hormone inhibit the growth of U-87MG human glioblastoma in nude mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02253.X

Isolation and sequencing of cDNAs for splice variants of growth hormone-releasing hormone receptors from human cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02253.X

Hypothalamic hormones and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02253.X

Antitumorigenic actions of growth hormone-releasing hormone antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02253.X

Inhibition of growth, production of insulin-like growth factor-II (IGF-II), and expression of IGF-II mRNA of human cancer cell lines by antagonistic analogs of growth hormone-releasing hormone in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02253.X

Expression of mRNA for growth hormone-releasing hormone and splice variants of GHRH receptors in human malignant bone tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02253.X

A potential autocrine pathway for growth hormone releasing hormone (GHRH) and its receptor in human prostate cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02253.X

Expression of growth hormone-releasing hormone (GHRH) and splice variants of GHRH receptors in human experimental prostate cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02253.X

The expression of growth hormone-releasing hormone (GHRH) and splice variants of its receptor in human gastroenteropancreatic carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02253.X

The expression of growth hormone-releasing hormone (GHRH) and its receptor splice variants in human breast cancer lines; the evaluation of signaling mechanisms in the stimulation of cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02253.X

Ligand-dependent and -independent effects of splice variant 1 of growth hormone-releasing hormone receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02253.X

Expression of a splice variant of the receptor for GHRH in 3T3 fibroblasts activates cell proliferation responses to GHRH analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02253.X

Expression of growth hormone-releasing hormone (GHRH) messenger ribonucleic acid and the presence of biologically active GHRH in human breast, endometrial, and ovarian cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02253.X

Expression of growth hormone-releasing hormone and its receptor splice variants in human prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02253.X

Decrease in telomerase activity in U-87MG human glioblastomas after treatment with an antagonist of growth hormone-releasing hormone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2005.02253.X

10.1111/J.1365-2265.2005.02253.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15853821%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference